| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
Acute myeloid leukemia: How to treat the fit patient over age 75?
|
Luger, Selina M.
|
|
|
32 |
4 |
p.
|
artikel
|
| 2 |
Beyond midostaurin: Which are the most promising FLT3 inhibitors in AML?
|
Wang, Eunice S.
|
|
|
32 |
4 |
p.
|
artikel
|
| 3 |
Can Ph-like ALL be effectively targeted?
|
Maese, Luke
|
|
|
32 |
4 |
p.
|
artikel
|
| 4 |
Can we selectively target AML stem cells?
|
Jordan, Craig T.
|
|
|
32 |
4 |
p.
|
artikel
|
| 5 |
Chimeric antigen receptor T cells (CAR-T) for the treatment of T-cell malignancies
|
Cooper, Mathew L.
|
|
|
32 |
4 |
p.
|
artikel
|
| 6 |
Does early diagnosis and treatment of myelodysplastic syndromes make a difference?
|
Steensma, David P.
|
|
|
32 |
4 |
p.
|
artikel
|
| 7 |
Does mutational burden add to other prognostic factors in MDS?
|
Nazha, Aziz
|
|
|
32 |
4 |
p.
|
artikel
|
| 8 |
Editorial Board / Aims & Scope
|
|
|
|
32 |
4 |
p.
|
artikel
|
| 9 |
How advanced are we in targeting novel subtypes of ALL?
|
Mullighan, Charles G.
|
|
|
32 |
4 |
p.
|
artikel
|
| 10 |
How close are we to CAR T-cell therapy for AML?
|
Gill, Saar I.
|
|
|
32 |
4 |
p.
|
artikel
|
| 11 |
Index
|
|
|
|
32 |
4 |
p.
|
artikel
|
| 12 |
Introducing article numbering to Best Practice & Research Clinical Haematology
|
|
|
|
32 |
4 |
p.
|
artikel
|
| 13 |
Is post-transplant cyclophosphamide a true game-changer in allogeneic transplantation: The struggle to unlearn
|
Jones, Richard J.
|
|
|
32 |
4 |
p.
|
artikel
|
| 14 |
MAGIC biomarkers of acute graft-versus-host disease: Biology and clinical application
|
Srinagesh, Hrishikesh K.
|
|
|
32 |
4 |
p.
|
artikel
|
| 15 |
Maintenance therapy after allogeneic hematopoietic cell transplantation for acute myeloid leukemia
|
Appelbaum, Frederick R.
|
|
|
32 |
4 |
p.
|
artikel
|
| 16 |
Post-remission therapy in acute myeloid leukemia: Are we ready for an individualized approach?
|
Derman, Benjamin A.
|
|
|
32 |
4 |
p.
|
artikel
|
| 17 |
Transplantation without pretransplant therapy: Is this a possibility? Insights into providing transplantation at diagnosis for patients with acute leukemia
|
Chao, Nelson J.
|
|
|
32 |
4 |
p.
|
artikel
|
| 18 |
What do functional genomics tell us about pathogenesis of AML?
|
Tyner, Jeffrey W.
|
|
|
32 |
4 |
p.
|
artikel
|
| 19 |
What have we learned from transplanting older patients?
|
Varadarajan, Indumathy
|
|
|
32 |
4 |
p.
|
artikel
|
| 20 |
What is the role of the microenvironment in MDS?
|
Calvi, Laura M.
|
|
|
32 |
4 |
p.
|
artikel
|
| 21 |
Which novel agents hold the greatest promise in AML?
|
DiNardo, Courtney D.
|
|
|
32 |
4 |
p.
|
artikel
|
| 22 |
Will new agents impact survival in AML?
|
Rowe, Jacob M.
|
|
|
32 |
4 |
p.
|
artikel
|
Tijdschrift beschrijving